Panelist Profile


Daniel Cheng Yong Lim

Kirkland & Ellis, Partner (UK)


Daniel C.Y. LIM is a partner in Kirkland & Ellis’ IP litigation team in London, where his practice is focused on complex and high-value life science patent litigation. He frequently acts for clients involved in pharmaceuticals, diagnostics and the emerging fields of cell and gene therapy, bringing his dual qualifications in law and biochemistry to bear.


In addition to UK litigation, Daniel often assists clients in devising and coordinating complex patent litigation strategy at a pan-European and global level, working closely with local lawyers around the world.


Daniel writes and speaks regularly on a wide range of life sciences and IP topics including precision medicine, CRISPR and biologics, and is co-author of the UK chapter of the upcoming AIPPI Law Series book on Antibody Patenting. He is a member of the AIPPI Standing Committee on IP and genetic resources/traditional knowledge and an observer on the Standing Committee on Biotechnology.